VIATRIS INC. Number of Reportable Segments
VIATRIS INC. (VTRS) reported Number of Reportable Segments of 4 right for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:NumberOfReportableSegments · last filed 2026-08-06
- VIATRIS INC. number of reportable segments for fiscal 2025 was 4.00 segment, a 0.00% change from fiscal 2024.
- VIATRIS INC. number of reportable segments for fiscal 2024 was 4.00 segment.
segment
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2025-12-31 | 4.00 segment 10-K · filed 2026-02-26 |
| 2024-12-31 | 4.00 segment 10-K · filed 2025-02-27 |
right
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month |
|---|---|---|---|
| 2026-06-30 | 4.00 right 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 4.00 right 10-Q · filed 2026-05-07 | ||
| 2025-09-30 | 4.00 right 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 4.00 right 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | 4.00 right 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |